Ledger.Open graph →
SEC Form D · filed July 25, 2022

Delfi Diagnostics, Inc

Offering
$225.0M
Sold
$225.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Baltimore, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Victor A. Velculescu · Baltimore, MDExec · Director · PromoterPeter Bach · Baltimore, MDExecMichael Dybbs · SOUTH SAN FRANCISCO, CADirectorJacob Van Naarden · Baltimore, MDDirectorJordan Gilman · Chicago, ILExec · Director · PromoterElizabeth Homans · South San Francisco, CADirectorRishi Gupta · New York, NYDirectorJustin Kao · San Francisco, CADirectorJennifer Buechel · Baltimore, MDExecGreg Yap · BALTIMORE, MDDirectorDouglas Schenkel · Baltimore, MDExecNicholas Dracopoli · BALTIMORE, MDExecJohn F. Pavlidis · Los Altos, CAExec · Director · PromoterPeter Bach · Baltimore, MDExecElizabeth Homans · South San Francisco, CADirectorRishi Gupta · Cambridge, MADirectorJustin Kao · San Francisco, CADirectorJennifer Buechel · Baltimore, MDExecGreg Yap · Menlo Park, CADirectorDouglas Schenkel · Baltimore, MDExecMichael Dybbs · SOUTH SAN FRANCISCO, CADirectorJacob Van Naarden · Baltimore, MDDirectorNicholas Dracopoli · BALTIMORE, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗